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Abstract This study describes the association between tail
necrosis in rabbits and mycotoxins in rabbit feed. Clinical
cases of tail necrosis were observed in 14 out of 103 rabbits
kept in an outdoor group housing, fed with hay and a com-
mercial pelleted feed. The observed clinical symptoms, alo-
pecia, erosions, crusts and necrosis were restricted to the tail
area and exclusively occurred in young rabbits aged 113±
20 days. Dermatological examination suggested that ischemia
had caused necrosis. Analysis of blood samples showed an
elevated level of creatine kinase. No weight loss occurred in
affected rabbits. Trauma caused by injuries or technopathic
lesions was also excluded. Histopathologically, the lesions
were characterized by acute muscle fibre degeneration and
chronic active dermatitis with granulation tissue formation.
Necropsy of one rabbit revealed hepatocellular degeneration
and necrosis as remarkable findings. Feed analysis for ergot
alkaloids by enzyme immunoassays yielded a mean and max-
imum ergot alkaloid content of 410±250 μg/kg and 1,700 μg/
kg, respectively. Faeces of affected rabbits contained ergot
alkaloids at levels up to 200 μg/kg. The mean and maximum
dietary intake of total ergot alkaloids were 17 and 71 μg/kg
bodyweight, respectively. Fusarium toxins (trichothecenes,
zearalenone, fumonisins) were also found in the feed, but at
levels which did not explain the observed effects. The results
indicate that ergot alkaloids may have been the cause of tail
necrosis, which is supported by literature data showing that
rabbits are especially sensitive towards these toxins.
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Introduction
Mycotoxins are a challenge in everyday agricultural practice
as there is fungal growth that subsequently causes
mycotoxicosis in about 25 % of the world’s crop (CAST
Task Force Report 2003), depending on environmental factors
like the climate as well as genetic contributions of the plants
themselves (Fink-Gremmels 1999). Mycotoxicosis due to
incorporation of various mycotoxins in the feed is known in
all farm animals, especially horses (Caloni and Cortinovis
2011), pigs (Colvin et al. 1993; Harvey et al. 1990; Kanora
and Maes 2009; Pang et al. 1986; Weissenbacher-Lang et al.
2012) and poultry (Shareef 2010) but also has been described
in pet animals such as in guinea pigs (Carlton and Tuite 1970).
Due to the modern agricultural methods, acute intoxications in
livestock animals are rare, while subacute or chronic progres-
sion is more common (Charmley et al. 1995). Adverse effects
depend on the type of toxic agent, the concentration and the
time of exposure (Fink-Gremmels 1999). Hepatic necrosis,
haemorrhage, icterus (Caloni and Cortinovis 2011), severe
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skin lesions like ear necrosis (Weissenbacher-Lang et al.
2012), myocardial and pancreatic lesions (Pang et al. 1986)
are found. Especially swine are considered as very sensitive to
these effects (Kanora and Maes 2009). In Europe, Fusarium
toxins (trichothecenes, zearalenone, fumonisins) are regarded
as the most important mycotoxins with regard to animal
health. For example, fumonisins lead to pulmonary edema,
thoracic effusions and hepatocellular necrosis (Colvin et al.
1993). In cattle, experimental dosing of T-2 toxin caused
necrosis of the tail tips, respectively red and encrusted lesions,
when administered orally or intramuscularly. Furthermore, a
severe intestinal haemorrhage could be found in necropsy
(Grove et al. 1970).
Ergotism caused by Claviceps purpurea is the oldest
known mycotoxicosis and is characterized by peripheral va-
soconstriction followed by ischemic acral necrosis in cattle,
goat, sheep and a number of other livestock species. After
being almost neglected over the past decades, ergot and ergot
alkaloids have regained scientific interest in recent years
(Bennett and Klich 2003; Ginn et al. 2007; EFSA 2005;
EFSA 2012). Very few information is available concerning
adverse effects of ergot alkaloids in rabbits. To the best of our
knowledge, only one reference gives some specific informa-
tion on toxicity data for ergotamine and ergometrine in rabbits
(Griffith et al. 1978). These authors report that rabbits are very
sensitive towards ergot alkaloids, although no detailed exper-
imental data are given in this publication (Table 1).
Several authors (for example, Filipov et al. 1998;
Panaccione et al. 2006) reported adverse nutritional effects
of ergot alkaloids in rabbits, such as feed avoidance or reduced
weight gain. These studies referred to ergovaline, which is an
ergot alkaloid produced by endophytic fungi, but not by
Claviceps spp., in grasses such as Lolium perenne and
Festuca arundinaceae. However, ergovaline seems to have
distinctively different toxicological properties compared with
ergot alkaloids produced by Claviceps spp. Furthermore, the
extracts used in these studies contained mixtures of ergovaline
and other clavine alkaloids or even other classes of toxins;
therefore, an unambiguous assignment of the effects is
difficult.
With the exception of fumonisins, no specific regulations
naming maximum levels of mycotoxins in rabbit feed exist.
The European Commission recommended that the level of
fumonisins in feed should not exceed 5 mg/kg. Other feed
recommendations include deoxynivalenol (DON), zearalenone,
T-2 toxin/HT-2 toxin and ochratoxin A (European Commission
2006; European Commission 2013), but these values are not
based on specific toxicity data from studies with rabbits. A
maximum level of 1,000 mg/kg of rye ergot sclerotia has been
established for feedingstuffs containing unground cereals by
European Union directive 2002/32/EC (European Union
2002). However, this regulation has limitations with regard to
toxicity of feed because (1) the alkaloid content of ergot is
variable, (2) sclerotia with different alkaloid pattern may occur
not only in rye but also in other cereals and (3) sclerotia cannot
reliably be determined in processed feed.
For example, ergot of rye sclerotia normally has an alkaloid
content of 0.03–0.1 % (Appelt and Ellner 2009; Franzmann
et al. 2011), but this value may go up to 1.5 % under
favourable conditions (Hulvova et al. 2013). Consequently,
the European Commission recently recommended that more
data on rye ergot and ergot alkaloids in food and feed should
be collected, with the intention to obtain reliable data on the
ergot alkaloid pattern in feed and food and to relate the
presence of ergot alkaloids to the amount of sclerotia present
(European Commission 2012). It is however foreseeable that
commercial rabbit feed will not play an important role in such
a monitoring programme.
In this paper, we report a case study of spontaneous
tail necrosis in a rabbit colony. Griffith et al. (1978)
have described tail gangrene in rats after intraperitoneal
injection of ergotoxin (ergocristine+ergocryptine+
ergocornine). Peripheral ischemia after intravenous dos-
ing of ergot alkaloids in several species, due to vaso-
constriction, has also been reported by these authors.
Although the clinical picture of ergot alkaloid intoxica-
tion in rabbits has not been described before, we there-
fore followed the hypothesis that ergot alkaloids could
have been the causative agents, or at least a contributing
factor, for the clinical observations.
Table 1 LD50 values for different
ergot alkaloids in rabbits, rats and
mice after intravenous (i.v.) or
oral application (data from
Griffith et al. 1978)
n.s. not specified
Alkaloid Rabbit Rat Mouse
LD50 (mg/kg body weight)
i.v. oral i.v. oral i.v. oral
Ergonovine (−metrine) 3.2 27.8 120 671 160 460
Ergotamine 3.0 550.0 38 1300 265 3200
Ergocornine 0.9 n.s. 95 >500 275 2000
α-Ergocryptine 1.0–0.8 n.s. 140 n.s. 275 n.s.
Ergocristine 1.9 n.s. 64–150 n.s. 110 n.s.
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Materials and methods
Animals and husbandry
A total of 103 rabbits were kept in an outdoor facility at the
teaching and research unit (Oberer Hardthof) of Justus Liebig
University Giessen, in groups of seven to nine animals per
cage on a perforated plastic floor. Male and female animals
were housed in separate compartments. They also had the
possibility to withdraw in a wooden box, spread with shavings
and straw. The stocking rate and the availability of space for
each animal were in accordance with European Union direc-
tive 63/2010 (European Union 2010).
Ethical statement: The animals were originally kept for a
breeding experiment approved by the local animal welfare
authorities (Regierungspräsidium Giessen; Gi 17/11 No. 65/
2011). The study was carried out according to the German
regulations with regard to animal welfare.
Animals were fed with hay and a commercial pelleted feed
preparation ad libitum and had unrestricted access to water
from a nipple drinker. The composition and the analytical
constituents of the pelleted feed are given in Table S1
(Supplementary material). After first tail lesions became vis-
ible and as soon as the feed was suspected to be a possible
cause of the disease, the feed from batch 1 was withdrawn and
submitted to mycotoxin analyses. For follow-up analyses,
pelleted feed (batches 2 and 3) of the same provider was then
fed to the animals and consecutively tested for mycotoxins as
well.
All rabbits in the colony were regularly vaccinated against
myxomatosis (Cunivak Myxo, IDT Biologika GmbH,
Dessau-Rosslau, Germany) and rabbit haemorrhagic disease
(Cunivak RHD, IDT Biologika GmbH, Dessau-Rosslau,
Germany) according to manufacturers’ specifications.
Clinical observations
The first rabbits with clinical symptoms of tail lesions were
observed on 12 November 2012. The last observed case was
on 07 January 2013. The mean age of the rabbits when
showing first clinical signs was 113±20 days. Until then, no
pathological findings were observed. Feed and management
factors were consistent since the start of the original breeding
experiment. The daily feed consumption was assessed by
weighing rabbits of two different groups and feed daily over
a 1-week period as basis to calculate the amount of mycotoxin
which was incorporated per kilogram bodyweight. Also, four
healthy adult rabbits of corresponding breeds were included in
this procedure to compare their dietary intake per kilogram
bodyweight with that of the affected growing animals. All
affected rabbits were weighted (Platform scales DE 60K20N,
Kern & Sohn GmbH, Balingen-Frommern) up to four times at
a 1-week interval, starting when the first lesions became
apparent.
In total, 14 rabbits, which were offspring of four different
breeding pairs, were clinically affected, and all of these affect-
ed rabbits were included in this study. Two unaffected animals
served as controls for the blood parameters.
To rule out behavioural abnormalities and injuries caused by
groupmates, the rabbits were observed in several intervals during
the day (for 10 min every 2 h) between 0700 hours (morning)
and 1700 hours (afternoon). Cages and housing equipment were
checked for possible sources of technopathic lesions.
Every affected animal underwent a complete general clin-
ical examination. The physiological range was determined
according to Schall (2008).
Blood samples were collected from three affected (82050,
82061, 82063) and two unaffected (82053, 82076) animals
and analysed for clinical chemistry (Pentra 400, Horiba,
Germany and Nova CRT 8, Nova Biomedical GmbH,
Roedermark, Germany) and haematology (ADVIA 120,
Siemens Healthcare, Eschborn, Germany).
Three rabbits (82050, 82059, 82063) underwent a detailed
dermatological examination 9 days after clinical lesions were
visible.
To avoid secondary infections, animals with ulcerative
lesions received antibiotic treatment with enrofloxacin
(Baytril 2.5 % solution, 0.4 ml per kg body weight, subcuta-
neous injection; Bayer AG, Leverkusen, Germany) for 5 days;
additionally, chlortetracycline was applied topically (CTC-
Blauspray, Novartis, Munich, Germany).
For two severely affected animals, tail amputation became
necessary because of cranial progression of the lesions.
Surgery was performed under ketamine hydrochloride/
medetomidine anaesthesia (Haberstroh and Enke 2004). The
amputated tails were then examined histopathologically.
Tissue was fixed in 10 % neutral buffered formalin and
embedded in paraffin using routine methods. Sections of
about 4-μm thickness were stained with haematoxylin and
eosin. One animal, which died 3 weeks after surgical inter-
vention, was subjected to gross pathology and histopathology.
Mycotoxin analyses
Feed samples taken from 44 bags, corresponding to three
different batches of the same brand of commercial feed, were
collected and analysed with competitive direct enzyme immu-
noassays (EIA, in-house methods) for total (generic) ergot
alkaloids (GEA-EIA) and ergotamine (ergotamine-EIA).
Additionally, four randomly selected samples of the second
batch were analysed by an EIA for fumonisins. More
Fusarium toxins, namely DON, T-2/HT-2 toxin and
zearalenone (one sample from each batch) were also tested
by EIAs. All tests were performed similarly as already de-
scribed by Liesener et al. (2010). Furthermore, three feed
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samples from other producers, obtained from rabbitries with-
out clinical signs of tail lesions, were analysed for total ergot
alkaloids and for ergotamine.
Pooled faecal samples of four groups of animals (F1–F4;
Table 2) were collected on five different days. Three of these
series of samples (F1, F2, F4) were from affected groups of
rabbits; the fourth series of samples (F3) was from a group of
unaffected animals of a similar age from the research station
(Table 2). Furthermore, samples of clinically symptom-free
rabbits, obtained from two other husbandries (F5–F7;
Table 2), were collected and also analysed for total ergot
alkaloids and for ergotamine.
Additionally, samples of hay (three small bales, 7 kg each)
which were fed to the rabbits and samples of straw (one 200-
kg round bale) which were used as bedding were also
analysed for ergot alkaloids. Macroscopically, no signs of
mould were visible in these materials. From each dry material,
a 300-g composite sample was collected, cut into pieces of 2-
to 4-cm length and further ground to a mean particle size of
<2 mm in a laboratory mill before analysis.
All EIAs were performed as standard microtiter plate tests.
Sample preparation was performed as already described ear-
lier (Liesener et al. 2010; Riemel 2012). At least three serial
dilutions of all extracts were analysed. All extract dilutions
resulting in absorbance values (B/B0×100) between 25 and
75 % were used to calculate the toxin content. Highly positive
extracts, resulting in absorbance values outside the measuring
range (<25 %), were further diluted and re-analysed by EIA.
Results
Clinical observations
The average daily feed intake of the affected (growing) rabbits
was 42 g per kg body weight, the average feed intake of adult
rabbits was 35 g per kg body weight.
The general clinical examination of all 14 affected rabbits
yielded results within a normal range, body weight develop-
ment was normal. Neither aberrant behavioural patterns with-
in each group of rabbits nor indications for technopathic
lesions were observed.
Symptoms were first observed in November 2012 in six
female rabbits (82050, 82052, 82059, 82060, 82061, 82063).
All affected animals showed, to varying degrees, moist, san-
guineous lesions at their tails, partly exposing the spine
(Fig. 1) and affecting predominantly the vertebrae caudales
at the distal part of the tail. About 2 days after the first
symptoms were observed, necrotic alterations were visible,
which progressed cranially and involved up to two thirds of
the tail (Fig. 2).
Eight more rabbits with symptoms of tail lesions were
identified within the next 55 days, the last animal with symp-
toms was detected on 07 January 2013. Four of these rabbits
(82054, 82057, 82064, 82066) had only mild skin alterations,
such as alopecia and scaling (Fig. 3), the other four animals
(82049, 82051, 82062, 82065) were more severely affected
and showed crusted erosions and ulcerations of the tails.
The blood biochemis t ry prof i le (Table S2,
Supplementary material) revealed through t test (95 %
confidence interval) significantly higher creatine kinase
values in the three affected rabbits (x=1846.7 U/l) com-
pared to the unaffected rabbits (x=680.5 U/l). Levels of
phosphorus and magnesium as well as alkaline phospha-
tase were slightly elevated both in affected and unaffected
rabbits. Haematology results (Table S3, Supplementary
material) were within physiological range.
Three rabbits (82050, 82059, 82063), which were present-
ed for dermatological examination, all showed varying de-
grees of alopecia, scales, multifocal crusted erosions and
ulcerations on the distal part of the tail. Other acra, namely
the ears, were not affected. Slight scaling on the back, due to
infestation with low numbers of fur mites (Leporacarus
gibbus), was detected in one rabbit (82050). Differential di-
agnoses included ischemic dermatopathies (vasculopathy,
Table 2 Rabbit groups for faecal sampling
Group
numbers
ID, animals in group affected (×)/
unaffected (−)
Groups from research station
F1 82049 m/ 82060 f ×
F2 82059 f/ 82065 f ×
F3 82073 f/ 82074 f/ 82075 f/ 82076 f −
F4 82052 f/ 82054 f/ 82063 f/ 82064 f ×
Groups from other husbandries
F5 husbandry 1; 2 rabbits (1 m/1 f) −
F6 husbandry 1; 2 rabbits (1 m/1 f) −
F7 husbandry 2; 3 rabbits (3 f) −
m male, f female
Fig. 1 Tail region of one severely affected rabbit (82050) with sanguin-
eous lesion. The lesion is located at the dorsal area and stretching over the
last third of the tail
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vasculitis, toxic or cold-induced vasoconstriction),
automutilation, barbering (trauma by cage mates),
technopathic lesions and—less likely—dermatophytosis for
cases with mild symptoms such as alopecia and scaling.
Histopathologically, the skin of the amputated tails was
multifocally ulcerated with serocellular hemorrhagic crusts
(Fig. 4a), hyperplasia of the surrounding epithelium
(Fig. 4b) and melanin incontinence. Further, histopathological
examination of tail tissue revealed an acute degeneration of
single-striated muscle fibres (Zenkers degeneration) of the tail
musculature (Fig. 4c), accompanied by regeneration. Other
observations included distinct formation of granulation tissue
in the subcutaneous tissue (Fig. 4b), single hair granulomas
and prominent periosteal hyperplasia of the coccygeal
vertebrae.
The deceased animal submitted for necropsy (82050) was
in a good nutritional state. The liver was firm, irregularly
mottled and showed multiple, sharply demarcated pale foci
(diameter 0.5–1.0 cm), multifocally distributed within the
parenchyma. The spleen was swollen due to acute congestion,
and there was an acute diffuse alveolar edema in the lungs.
Histopathologically, the liver showed multifocal areas of
coagulative necrosis (Fig. 4d), randomly distributed with in-
filtration by neutrophils and macrophages. There was a mild
anisocytosis and anisokaryosis of hepatocytes, and single
binucleated cells were detected. Additionally, a marked chron-
ic cholangitis and pericholangitis with fibrosis and bile duct
hyperplasia (Fig. 4d), as well as an acute myofibril degener-
ation and necrosis with dystrophic mineralization in the myo-
cardium, were observed (Fig. 4e). Other examined tissues and
organs were without any remarkable lesions.
Mycotoxin analyses
Mycotoxin analyses for Fusarium toxins by EIA yielded
performance data similar as described previously (Liesener
et al. 2010). For the total ergot alkaloid (TOT) EIA, the
detection limit in rabbit feed was 50 ng/g, in rabbit faeces, it
was 20 ng/g. Mean recoveries at spiking levels of 100–
1,000 ng/g were 154–219 % in rabbit feed and 79–112 % in
rabbit faeces. The detection limit of the ergotamine EIA in
rabbit feed was 80 ng/g, in rabbit faeces, it was 30 ng/g. In
rabbit feed and rabbit faeces spiked with ergotamine at levels
of 100–1,000 ng/g, mean recoveries were 155–178 % and 92–
336 %, respectively.
Total ergot alkaloids (TOT) could be detected in all 44
samples from three batches of the commercial rabbit feed, at
a mean concentration of 410 ng/g (range 140–1,700 ng/g).
Ergotamine (TAM) could also be detected in all samples, in a
mean concentration range of 370 ng/g (range 140–910 ng/g).
An overview of analytical results is given in Table 3. In feed
samples of animal groups from husbandries without clinical
symptoms, the concentration of total ergot alkaloids was 85–
290 ng/g (mean 160 ng/g; n=3), the concentration of ergota-
mine was 120–140 ng/g (mean 130 ng/g; n=2).
Low levels of fumonisins could also be found in all four
samples in a concentration range of 5.3–6.5 ng/g. All analysed
samples, three from each feed batch, also contained DON
(260–540 ng/g), T-2 toxin/HT-2 toxin (8.7-17 ng/g) and
zearalenone (105–130 ng/g).
Rabbit faeces samples both from the affected animal
groups (F1, F2, F4) and from the unaffected group (F3)
contained total ergot alkaloids in a concentration range of
51–180 ng/g (mean 110 ng/g, n=20) (Fig. 5) and ergotamine
in a concentration range of 44–260 ng/g (mean 140 ng/g, n=
20) (Fig. 6). The mean levels of groups F1, F2, F3 and F4
were 150, 93, 92 and 106 ng/g in the total ergot alkaloid EIA.
The corresponding values in the ergotamine EIA were 194,
130, 136 and 146 ng/g. The five samples of faeces from
clinically symptom-free animals contained no detectable ergot
alkaloids in the total alkaloid EIA, and only traces (30–40 ng/
g) were detected in the ergotamine EIA, close to the detection
limit of the test.
Fig. 2 Tail region of one severely affected rabbit (82060) with necrotic
lesion. The spine at the tail tip is visible (arrow), following necrosis of the
skin tissue (lateral view)
Fig. 3 Tail region of one affected rabbit (82057) with fur loss. Mild skin
alterations like alopecia and scaling are visible (dorsal view)
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No ergot alkaloids could be detected in straw and hay
samples (detection limit 130 ng/g).
Discussion
In this case series, 14 out of 103 rabbits, living under equal
conditions, spontaneously showed tail lesions. Exclusively,
young, growing animals were affected. As a comparable
outbreak has never been reported before in scientific literature,
we put some effort in identifying the likely causative factors.
We assumed that the tail lesions may be the result of
peripheral ischemia due to vasoconstriction caused by myco-
toxins, most likely by ergot alkaloids. In the histopathological
examination, acute muscle fibre degeneration was coexisting
with a chronic inflammation with granulation tissue forma-
tion. Vasculitis or thrombosis was not detectable.
The lesions observed in the deceased rabbit (hepatocellular
degradation and regeneration, as well as fibrosis, bile duct
Fig. 4 Histopathological findings in tail and organ tissue of affected
rabbits. a Pyodermic tail. Please note the thick serocellular crust (asterisk)
composed of degenerated leucocytes, keratin and blood cells (HE, ×20). b
Skin beneath ulceration. The figure is showing epithelial hyperplasia
(arrowhead) and chronic dermatitis with granulation tissue formation
(arrows) (HE, ×20). c Degenerating muscle fibres. Hypereosinophilia
and loss of myofibrils characterize degenerating muscle fibres of the tail
in cross section (HE, ×20). dHistopathology of the liver of the necropsied
animal (82050). Multiple foci of acute coagulative necrosis (arrowhead),
bile duct hyperplasia, chronic cholangitis and pericholangitis (arrow)
(HE, ×20) are shown. e Myocardial fibre necrosis. Acute myocardial
fibre necrosis with dystrophic mineralization (asterisk) is visible in the
heart of the necropsied animal (HE, ×40)
Table 3 EIA results for total ergot alkaloids (TOT) and ergotamine (TAM) in rabbit feed
Batch 1 Batch 2 Batch 3 Batches 1–3
TOT TAM TOT TAM TOT TAM TOT TAM
n* 4 4 26 26 14 14 44 44
mean, μg/kg 570 650 400 370 370 290 410 370
SD, μg/kg 190 190 300 110 150 95 250 150
median, μg/kg 560 620 310 350 320 300 330 350
min, μg/kg 360 470 150 190 140 140 140 140
max, μg/kg 780 910 1700 760 680 430 1700 910
*Number of analysed samples from a total of 44 different 25-kg bags, three batches of feed from the same brand
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hyperplasia, myocardial necrosis) could have been a possible
consequence of a toxin or a toxic effect (Stalker and Hayes
2007). Such lesions are not toxin specific but have been
described in association with other mycotoxins like
fumonisins in swine (Colvin et al. 1993).
Considering the feed composition, the presence of
Fusarium toxins was suspected. Indeed, Fusarium toxins
were found in all feed samples, but at low or moderate levels
in all samples. The highest levels were found for
deoxynivalenol (DON) (404±140 ng/g) but this can be ad-
dressed as a concentration which is commonly found in
cereal-based feedstuff. The DON level was considered far
too low to cause typical acute toxic effects, which are primar-
ily characterized by feed refusal and reduced weight gain. This
assumption is supported by recent data from toxicological
studies (Hewitt et al. 2012) with 5-week-old New Zealand
White rabbits, which suggest that rabbits are more tolerant
towards DON than other species. Hewitt et al. (2012) reported
that DON levels of 4.2 mg/kg in the feed, about ten times
higher than those found in our study, had little effect on young
fryer rabbits, only some blood parameters were slightly
modified.
Although no toxicological data are available for rabbits, it
can be assumed that the levels of zearalenone found in feed
were also below levels which are normally involved in typical
zearalenone-associated symptoms of hyperestrogenism.
Furthermore, no such symptoms, which would indicate estro-
genic effects, were observed. Finally, only trace amounts of
fumonisins and T-2 toxin/HT-2 toxin were present in feed
samples, well below levels which are regarded as toxic and
also well below guidance value for fumonisins (European
Commission 2006) and “indicative levels” for T-2 toxin/HT-
2 toxin (European Commission 2013). Therefore, it seems
unlikely that Fusarium toxins were associated with the ob-
served effects.
In contrast, the results obtained for ergot alkaloids
were regarded as toxicologically relevant. While hay
and straw samples were free from ergot alkaloids, anal-
ysis of pelleted commercial rabbit feed yielded surpris-
ingly high levels of ergot alkaloids in both EIAs. In
Europe, rye, triticale, wheat, maize, oats and barley are
the most susceptible cereals for contamination with
Claviceps spp. Based on product specifications, the pel-
lets fed to the rabbits contained 15 % wheat bran, 10 %
peeled oat bran, 10 % wheat gluten feed and 3.1 %
barley as possible sources of ergot alkaloids (Table S1,
Supplementary material).
Considering factors such as analytical variability and sam-
ple homogeneity, the total ergot alkaloid content was relative-
ly similar in most samples but a few had exceptionally higher
toxin contents, with a maximum level of 1,700 ng/g (Table 3).
Ergotamine seemed to be the predominant alkaloid in these
samples but because of some cross-reactivity of ergocristine in
the ergotamine EIA, this alkaloid may also have added to the
ergotamine EIA results (Table 3). Because the mycotoxin
analysis of rabbit feed started only after the clinical signs
had become apparent, samples of the previous feed batches,
used before November 2012, had not been available for anal-
ysis. Therefore, a clear association between ergot alkaloid









































Fig. 5 Time course of ergot alkaloids in rabbit faeces (total ergot alkaloid
EIA results). Faecal samples were from four groups (F1, F2, F4 affected;
F3 unaffected; see Table 2) from the research station were collected on
five different days. The EIA limit of detection (LOD) was 20 ng/g. The
average total ergot alkaloid concentration of all samples was 110 ng/g.
Five faecal samples from three other groups (F5–F7) of rabbits from two





























Fig. 6 Time course of ergot alkaloids in rabbit faeces (ergotamine EIA
results). Faecal samples from four groups (F1, F2, F4: affected; F3:
unaffected; see Table 2) from research station were collected on five
different days. The EIA limit of detection (LOD) was 30 ng/g. The
average ergotamine concentration of all samples was 140 ng/g. When
five faecal samples from three other groups (F5-F7) of rabbits from two
other husbandries were analysed, two yielded weakly positive results
close to the detection limit (30–40 ng/g)
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However, as the relative feed intake of clinically affected,
growing rabbits was distinctly higher (42 g per day and kg
body weight) than that of healthy adult rabbits (35 g per day
and kg body weight), toxic effects caused by ergot alkaloids
are expected to be more pronounced in young rabbits. Using
the average daily feed intake of 42 g per kg body weight of
growing rabbits and the mean total ergot alkaloid content in
feed (410 ng/g), the mean ergot alkaloid intake was calculated
to be 17μg per kg body weight. Using the same intake and the
maximum ergot alkaloid levels found in one sample
(1,700 ng/kg), the maximum daily alkaloid intake could be
estimated to be 71 μg per kg body weight. However, it has to
be considered that coprophagy of soft pellet faeces results in a
re-ingestion and a second passage of ergot alkaloids.
Therefore, the effective ergot alkaloid intake may have been
much higher.
Interestingly, relatively high levels of ergot alkaloids
were found in faeces from the three affected groups F1,
F2 and F4. Groups F1 and F4 contained the most severely
affected rabbits, while symptoms in group F2 were some-
what milder. Group F3 which was unaffected had slightly
lower total ergot alkaloids in faeces, but was still positive.
This is no surprise because all animals in groups F1–F4
received the same feed (Figs. 5, and 6). These findings
may, speculatively, indicate that the total ingested amounts
of ergot alkaloids were borderline in aspects of toxic
effects. In contrast, five samples of faeces from three
different groups obtained from two other private hus-
bandries, with no clinical symptoms, were all negative
for total ergot alkaloids, and only two yielded weakly
positive results close to the detection limit in the ergota-
mine EIA.
Our hypothesis is that ergot alkaloids in rabbit faeces could
possibly provide a marker for the oral intake level of myco-
toxins and that the intake levels observed in this study cir-
cumscribe the toxicologically relevant dose.
Furthermore, as rabbits are a coprophagic species, ergot
alkaloids in faeces undergo a recycling process, which could
enhance toxin resorption. In fact, high ergot alkaloid levels
were found in the faeces in the animal groups with clinical
symptoms, while faeces from clinically symptom-free rabbits
mostly contained no detectable alkaloids at all, and only trace
amount levels were measured by the ergotamine EIA in two
samples.
Gangrene of extremities (ear, tail, hoofs, combs) has been
described for many animal species (Griffith et al. 1978;
Diekman and Green 1992). Therefore, an exposure to ergot
alkaloids seems to be a reasonable explanation for the ob-
served symptoms. However, little is known about symptoms
of acute or chronic exposure to ergot alkaloid in rabbits, and
no data are available concerning the minimum effective oral
dose. Therefore, our findings cannot provide clear evidence
that ergot alkaloid intoxication was the cause of disease in the
rabbits. Consequently, we carefully considered differential
diagnoses.
Environmental and behavioural factors, such as
technopathic lesions due to unsuitable housing equipment,
automutilation or injuries caused by cage mates were consid-
ered but could be excluded on the basis of animal observation
and after careful inspection of the housing facilities. Due to the
restriction of lesions to the distal part of the tail in all animals,
infections such as dermatophytosis seemed to be unlikely.
Indeed, no dermatophytes were found in histological exami-
nation of PAS stained samples.
Although no indications of vasculopathy or vasculitis
could be observed in the biopsies, these pathomechanisms
could not be excluded. One possible aetiology for vasculitis
could have been systemic infection, but neither clinical exam-
ination nor the laboratory data provided any evidence for that.
The blood analysis revealed an elevated level of creatine
kinase in the three affected rabbits. This was considered to
be due to localized rhabdomyolysis in the tail (Aroch et al.
2010; Goto et al. 2009; Lefebvre et al. 1996). Septic diseases
could also lead to an elevated level of creatine kinase because
of a more generalized rhabdomyolysis (Mazaki-Tovi and
Aroch 2000) but the affected rabbits never showed physical
discomfort and aberrant physical parameters. No weight loss
was evident in any animal during the period of observation.
Because the affected rabbits were still adolescent, slightly
elevated phosphorus and alkaline phosphatase levels were
considered as within physiological range (Hein and
Hartmann 2003). Slightly increased magnesium levels were
considered as of no clinical relevance. No other immunologic
stimulus was noted except vaccination, given 3 days to
3 months before the first clinical signs were observed. In dogs,
ischemic dermatopathies after rabies vaccination are described
(Gross et al. 2005; Vitale et al. 1999). Typical clinical signs of
chronic ischemia include dry scaly skin, cutaneous atrophy
and acral necrosis and resemble those lesions described here.
Although vaccination as an immunological trigger for
vasculitis could not be excluded, it was also regarded as
unlikely because of the complete healing in most animals
observed during the outbreak.
Hereditary diseases as a cause of the observed symptoms
were also regarded as unlikely because the affected rabbits
were offspring of four different breeding pairs.
After all these differential diagnoses had been excluded, a
dietary poisoning effect was considered as the most likely
cause of the observed symptoms. This is somehow supported
by Griffith et al. (1978) who reported tail necrosis as a symp-
tom of ergot alkaloid poisoning in rats. This assumption was
further supported by the observation of individual animals.
Animals of high rank in each group, having more frequent
access to the pelleted food, were the first to show tail lesions
and also were most severely affected. Likewise, young, grow-
ing rabbits with a high pellet intake had higher faecal deposits
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of total ergot alkaloids and ergotamine. Consequently, their
dietary intake of ergot alkaloids was probably above average.
One contributing factor to the severity of the clinical symp-
toms could have been the prevailing climatic conditions during
the outbreak. The observed onset of symptoms was on 12
November 2012. The last symptoms were observed on 07
January 2014. Therefore, all clinical cases occurred duringwinter
2012/2013, with average monthly temperatures of 3–5 °C and
night time ambient temperatures mostly at or below 0 °C. The
animals were housed under open, stable climate conditions, with
sufficient shelters for protection against freezing, which is
regarded as a species-appropriate condition for rabbits.
Although the dose-dependent vasoconstrictory potential of ergot
alkaloids remained the same, the severity of clinical effects may
have been enhanced by a reduced physiological blood flow to the
periphery, triggered by low ambient temperatures. It seems to be
possible that neither factor alone would have caused adverse
effects but that dietary ergot alkaloids plus low ambient temper-
ature had worked synergistically.
In cattle, “fescue foot”, which is a gangrenous form of
ergotism, primarily occurs during the cold season, while in
summer, hyperthermia is more prevalent. Rabbits are very
sensitive towards hyperthermia induced by ergot (Haschek
and Voss 2013), but no information could be obtained with
regard to low ambient temperature.
It seems however reasonable to assume that low ambient
temperature, particularly on the floor area of the rabbit hous-
ings, may likewise have enhanced the vasoconstrictory effects
of ergot alkaloids, especially in young rabbits with low body
weight and high toxin intake. This would also give some
explanation for the fact that the tail and not the ears was
affected in young rabbits because the tail region was most
likely more exposed to lower temperatures than the ears.
Additionally, this would be consistent with the observation
that the symptoms disappeared as soon as the rabbits reached
adulthood, in spite of continuing exposure to ergot alkaloids;
in adults, the ergot alkaloid-induced vasoconstriction would
be less effective. It seems essential that such temperature-
modulated effects should be considered in future studies on
the adverse effects of ergot alkaloids in rabbits.
At present, it is unclear what the safe levels of ergot
alkaloids in rabbits would be. The European Union regula-
tions concerning ergot sclerotia in feed (European Union
2002) would correspond to a tolerance value for ergot alka-
loids of 1,000 μg/kg, if an average alkaloid content of 0.1 % is
assumed. The total ergot alkaloid content inmost feed samples
in our study was close to this level but exceeded it only in a
few samples. If our assumption that ergot alkaloids in feed
have caused or at least contributed to the clinical symptoms is
correct, this would have practical consequences for manufac-
turers of commercial feedingstuff for rabbits.
To consistently avoid symptoms such as tail lesions and
necrosis in younger rabbits, the mean ergot alkaloid content in
such feed must be controlled and kept as low as possible.
Furthermore, higher awareness of ergot-related toxicosis in
rabbits may eventually yield a better overview about the
overall situation in rabbit farming. Seasonal variations may
be a critical factor, influencing severity of outbreaks under
open-climate housing conditions, with gangrenous symptoms
in the winter and possibly hyperthermia in summer.
However, to fully confirm that dietary ergot alkaloids at
concentration levels of around 500 μg/kg may act as a caus-
ative agent of mycotoxicosis in rabbits, as well as to determine
safe levels in feed, controlled feeding trials under various
conditions would be necessary. We conclude that our results
provide sufficient evidence to justify such studies, with the
aim to prevent and correctly diagnose ergot-related health
problems in rabbit farming.
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